TTA has an open invitation to industry leaders to contribute to our Perspectives non-promotional opinion and thought leadership area. Today’s contribution is from Jodi Amendola, CEO of Amendola, a full-service PR and marketing agency that focuses on healthcare, health tech, and life sciences. Your Editor personally knows Amendola as a leading US agency representing many leading companies ably and well in both earned and paid media. In this article, Jodi explains some best practices in working with your PR and/or marketing agency–why their specialized skills in dealing with the media are necessary–and getting the most out of your mutual commitment.... Continue Reading
Search Results for ✅🧯 Cialis super active, tadalafil, 20mg online ↣ 🐯💤 www.USPharm.ORG 📞✔ ↢. no prescription pharmacy✍➡:wcvendor.awesomesupport.com/cialis-super-active-br, cialis soft tabs,buy tadalafil 20mg,tadalafil us,generic cialis 40mg,real cialis 20mg
Mid-week news roundup: US offers $10M for BlackCat/ALPHV info; most Change systems still down; Risant closes Geisinger buy; SureScripts exploring sale; DarioHealth 2023 revenue -23%; Amazon Pharmacy same-day delivery NYC and LA
...delivery available in Phoenix, Austin, Seattle, Indianapolis, Miami, and Texas, including free drone delivery in College Station. How it works: Amazon has small facilities and pharmacists near the areas, ready to fill and deliver medications in minutes using genAI and machine learning tools. Delivery in NYC/Manhattan will be by bike and in LA, electric vans or other commercial vehicles. (Editor’s note: bike delivery in the outer boroughs is like LA–impractical.) Amazon Prime members have additional benefits. Competition here are online companies like Mark Cuban Cost Plus and GoodRx’s prescription service. But perhaps it’s a good time to sell Surescripts? Mobihealthnews... Continue Reading
Short takes: PocketHealth, Brightside fundings; VA OIG reports hit Oracle Cerner; Change cyberattack/legal updates; UHG-Amedisys reviewed in Oregon; Optum to buy Steward Health practices
It’s a relatively quiet week before the Easter holiday, with a few fundings, more drama at the VA around Oracle Cerner, updating Change Healthcare’s comeback, and the continuing scrutiny around UnitedHealth’s acquisitions: PocketHealth garners a US$33 million Series B. The Toronto-based company markets an AI-assisted platform to health systems and providers that allows patients to access their medical imaging and reports as well as for providers to easily share imaging information. The funding was an all-equity round by Round13 Capital with participation from Deloitte Ventures, Samsung Next, and existing investors Questa Capital and Radical Ventures to bring total funding since... Continue Reading
Can digital health RPM achieve meaningful change with type 2 diabetics? New metastudy expresses doubt.
...also disproportionately affects people of color and those with lower income, especially as they age. The systematic literature review of 1,100-plus studies was augmented by interviews with physicians, patients, digital health experts, along with companies. They included 120 clinical references from DarioHealth, Omada, and Virta. The PHTI grouped digital tools into three types of solutions for Type 2 diabetes in adults. All used standard glucometers, not continuous glucose monitors/CGM as well as apps to provide real time feedback to a virtual or actual coach or care team: Remote patient monitoring (glucometer plus feedback): Glooko Behavior/Lifestyle modification (glycemic feedback plus coaching... Continue Reading
Why is the US DOJ filing an antitrust lawsuit against Apple–on monopolizing the smartphone market?
...and the Apple ‘walled garden’, Apple has a legitimate competitive feature. Companies don’t have a ‘duty to deal’ with other companies Apple as a monopoly has already been dismissed in other cases The push towards the DOJ action has apparently been stimulated by the EU Digital Markets Act, which Apple will comply with, as well as Apple competitors in the US who have tried and failed to restrict Apple in integrating its services. Will DOJ succeed in forcing Apple to be more like Android? The debate will rage on. DOJ release, 88 page filing, The Verge, 9to5 Mac, Medium.com, AP,... Continue Reading
Mid-week roundup: UK startup Anima gains $12M, Hippocratic AI $53M, Assort Health $3.5M; Abridge partners with NVIDIA; VillageMD sells 11 Rhode Island clinics; $60 for that medical record on the dark web
It may be a little chilly out, but it feels like Springtime For Early Round Funding and Big Partnerships. Anima, a London-based startup fresh out of Y Combinator, now has a $12 million Series A raise. It was led by Molten Ventures, with participation from existing investors Hummingbird Ventures, Amino Collective and Y Combinator. Its platform combines online consultation with productivity tools for integrated care enablement in one dashboard for primary care. Their founders position it as a single source for patient truth across care settings, avoiding missed diagnoses. As of today, Anima is deployed in over 200 NHS clinics... Continue Reading
News roundup: Cerner goes live at VA, DOD Lovell Center; WebMD expands education with Healthwise buy; Dexcom has FDA OK for OTC glucose sensor; Centene may have buyer for abandoned Charlotte HQ
...in the US. Like the prescription version, the biosensor attaches to the arm to monitor blood glucose without skin penetration and connects to a Dexcom phone app. The sensor is the same as the prescription Dexcom G7, with a battery life of about 15 days. Stelo was cleared for use by adults 18+ who have Type 2 diabetes but not on insulin therapy–over 25 million people in the US. Release is scheduled for online-only release this summer as a cash-pay purchase (cost not disclosed), with insurance reimbursement TBD over the next few years. Mobihealthnews, Healthcare Dive Centene may be close... Continue Reading
Updates on Change cyberattack: UHG’s timeline for system restorations, key updates around claims and payments in next weeks (updated)
As of 8 March-updated 14 March UnitedHealth Group released a timeline on restoring Change Healthcare systems. Prescribing is currently back online, with payments not up until next Friday and the claims network starting testing and brought up through the week of 18 March. Highlights below are from the release. Details in 7 March press release. Electronic prescribing is now fully functional with claim submission and payment transmission available as of 7 March. At the end of the release, there is additional information applicable to pharmacy claims and payments, as well as Optum Rx PBM. Update: UHG announced on 13 March... Continue Reading
Reality Bites Again: UHG being probed by DOJ on antitrust, One Medical layoffs “not related” to Amazon, the psychological effects of cyberattacks
When It Rains, It Really Pours for UnitedHealth Group. On the heels of their Optum/Change Healthcare ransomware disaster are recent reports that the US Department of Justice is investigating UHG over multiple antitrust concerns. According to the Wall Street Journal, DOJ is examining certain relationships between the company’s UnitedHealthcare insurance unit and its Optum services unit, specifically around Optum’s ownership of physician groups. UHG has been aggressively buying and buying interests in practice groups for several years, announcing quite publicly that their goal was to own or control 5% of US physicians. In 2022 and 2023, they bought CareMount, Kelsey-Seybold,... Continue Reading
Facing Future: Walgreens CEO moves company into strategic review–will he get WBA board alignment?
...of shares with other insiders (including the COO of WBA International, Ornella Barra, spouse of Mr. Pessina) having about 17%. Large institutional investors (Vanguard, State Street, etc.) have over 60% of the company. The share price has fallen about 40% in the past year (from early March 2023) and 55% from this time in 2022. (Derived from WBA and Yahoo Finance) Example: This Editor has estimated from public information that Walgreens sank north of $10 billion into VillageMD, from initial and then controlling interest, then funding the buy of Summit Health/CityMD. This is a huge and recent investment that is... Continue Reading
Most Recent Comments